Drugs / Ayahuasca

Trials 6 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/21 trial
Phase 1/2 NCT02914769 Feb 2014 → Dec 2016 major depressive disorder Federal University of Rio Grande do Norte Completed No outcome recorded
Phase 23 trials
Phase 2 NCT07317206 Dec 2025 → Jun 2026 overdue post-traumatic stress disorder University of Sao Paulo Recruiting No outcome recorded
Phase 2 NCT07212946 Oct 2022 → Oct 2024 major depressive disorder University of Sao Paulo Completed No outcome recorded
Phase 2 NCT06150859 Oct 2021 → Apr 2024 Beckley Med Foundation Unknown No outcome recorded
Phase not applicable2 trials
NCT07317232 Dec 2025 → Jun 2026 overdue University of Sao Paulo Recruiting No outcome recorded
NCT07317219 Dec 2025 → Jun 2026 overdue University of Sao Paulo Recruiting No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT05894902 Comparator Oct 2023 → Apr 2024 major depressive disorder, post-traumatic stress disorder Advanced Integrative Medical Science Institute Unknown No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as Ayahuasca “This paper introduces a protocol for a clinical trial exploring the effectiveness of a Meaning Reconstruction psychotherapy approach (MR) assisted with ayahuasca, a traditional...” PMID 39839135 Jan 2025
5

NCT07317232

NCT07317206

NCT07317219

NCT02914769

NCT07212946

Known as SM-001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05894902
Modality Traditional medicine (herbal / TCM) “Ayahuasca is a decoction of two plants, long used by Amazonian Amerindians.” NCT02914769
Route Oral “Effects begin at 30-40 min after oral intake” NCT02914769